Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
BioVie, Inc.
BioVie, Inc. is an antibiotics, cirrhosis therapies founded in 2013 by Cuong Do.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
Board of Directors
Sig Rogich
0
Cuong Do
0
Terren Peizer
0
CAGE Code
803C6
0
CEO
Cuong Do
0
CIK Number
1,580,149
0
Legal Name
BioVie Inc.
Company Operating Status
Active
Contact Page URL
bioviepharma.com/contact-us/
Country
United States
Crunchbase URL
crunchbase.com/organiz...n/biovie
DUNS Number
073659102
0
Email Address
info@bioviepharma.com
0
info@biovieinc.com
Facebook URL
@BioVieInc
Founded Date
January 1, 2013
Founder
Cuong Do
Full Address
680 W. Nye Lane, Suite 201, Carson City, NV 89703, USA
0
Industry
Neurodegenerative Disease
Biomedical engineering
Biopharmaceutical
Pharmaceutical industry
Technology
Biology
Biotechnology
Healthcare
Medicine
Neurobiology
•••
IRS Number
462,510,769
0
Latest Funding Round Date
July 25, 2022
Latest Funding Round Amount (USD)
6,000,000
LinkedIn URL
@company/biovie-inc.
Location
Carson City, Nevada
0
Beverly, Massachusetts
NAICS Code
325,412
0
Number of Employees (Ranges)
1 – 10
Patents Assigned (Count)
1
Phone Number
+13122835793
+17758883162
0
Pitchbook URL
pitchbook.com/profiles.../57789-28
Place of Incorporation
Nevada
0
Previous Name
NANOANTIBIOTICS, INC.
0
SIC Code
2,834
0
Exchange
Nasdaq
0
Stock Symbol
BIVI
0
Ticker Symbol
BIVI
Total Funding Amount (USD)
6,000,000
Twitter URL
@biovie_inc
Official Website
biovieinc.com
bioviepharma.com
Find more companies like BioVie, Inc.
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE